Monteith; David

Patent Applications and Registrations

Patent applications and USPTO patent grants for Monteith; David.The latest application filed is for "sustained release formulation and tablets prepared therefrom".

Company Profile

0.11.20

Monteith; David - Pittstown NJ
Monteith; David - Buckinghamshire GB
Monteith; David - Worminghall GB
MONTEITH; DAVID - Thomasville GA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Sustained release formulation and tablets prepared therefrom Grant 10,207,002 - Gupta , et al. Feb	2019-02-19
MEMS microphone assembly Grant 10,009,694 - Sibbald , et al. June 26, 2	2018-06-26
Sustained Release Formulation And Tablets Prepared Therefrom App 20180154000 - Gupta; Pranav ; et al.	2018-06-07
Mems Microphone Assembly App 20180041843 - Sibbald; Alastair ; et al.	2018-02-08
Posaconazole intravenous solution formulations stabilized by substituted .beta.-cyclodextrin Grant 9,358,297 - Heimbecher , et al. June 7, 2	2016-06-07
Intravenous Formulations Of Neurokinin-1 Antagonists App 20160024092 - Wan; Jiansheng ; et al.	2016-01-28
Phenylephrine Pharmaceutical Formulations And Compositions For Colonic Abosorption App 20150290147 - Monteith; David ; et al.	2015-10-15
Posaconazole Intravenous Solution Formulations Stabilized By Substituted Beta-cyclodextrin App 20150265715 - Heimbecher; Susan K. ; et al.	2015-09-24
Intravenous formulations of neurokinin-1 antagonists Grant 9,101,615 - Wan , et al. August 11, 2	2015-08-11
Posaconazole intravenous solution formulations stabilized by substituted .beta.-cyclodextrin Grant 9,023,790 - Heimbecher , et al. May 5, 2	2015-05-05
Phenylephrine pharmaceutical formulations and compositions for colonic absorption Grant 8,956,662 - Monteith , et al. February 17, 2	2015-02-17
Earphone Arrangements App 20140211970 - SIBBALD; Alastair ; et al.	2014-07-31
Posaconazole Intravenous Solution Formulations Stabilized By Substituted Beta-cyclodextrin App 20130096053 - Heimbecher; Susan K. ; et al.	2013-04-18
Corticosteroid Compositions And Methods Of Treatments Thereof App 20120022032 - Wan; Jiansheng ; et al.	2012-01-26
Fluid Injection System App 20110162738 - KUHNLE; CARL ; et al.	2011-07-07
Method and apparatus for fluid pressure testing Grant 7,950,266 - Kuhnle , et al. May 31, 2	2011-05-31
Fluid injection system Grant 7,926,503 - Kuhnle , et al. April 19, 2	2011-04-19
Intravenous Formulations Of Neurokinin-1 Antagonists App 20110038925 - WAN; Jiansheng ; et al.	2011-02-17
Ph Sensitive Matrix Formulation App 20100081672 - Wan; Jiansheng ; et al.	2010-04-01
Phenylephrine Pharmaceutical Formulations And Compositions For Transmucosal Absorption App 20090280160 - Monteith; David ; et al.	2009-11-12
Method And Apparatus For Fluid Pressure Testing App 20090178463 - KUHNLE; CARL ; et al.	2009-07-16
Rapidly Disintegrating Lyophilized Oral Formulations Of A Thrombin Receptor Antagonist App 20080152712 - Monteith; David ; et al.	2008-06-26
Phenylephrine Pharmaceutical Formulations and Compositions for Colonic Absorption App 20080020055 - Monteith; David ; et al.	2008-01-24
Fluid Injection System App 20070267070 - Kuhnle; Carl ; et al.	2007-11-22
Controlled-release formulation of HCV protease inhibitor and methods using the same App 20070237818 - Malcolm; Bruce A. ; et al.	2007-10-11
Rapidly Absorbing Oral Formulations Of Pde 5 Inhibitors App 20070122355 - Monteith; David ; et al.	2007-05-31
Rapidly absorbing oral formulations of PDE 5 inhibitors App 20070031349 - Monteith; David ; et al.	2007-02-08

Company Registrations

SEC

0001663077

MONTEITH DAVID

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.